RCKT Stock Analysis: Buy, Sell, or Hold?
RCKT - Rocket Pharmaceuticals, Inc. Common Stock
$3.34
-0.07 (-2.05%)
âŧ
5d:
-5.65%
30d:
-8.49%
90d:
-7.22%
WAIT
LOW Confidence
Analysis Updated: Aug 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When RCKT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: RCKT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: RCKT is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: RCKT is currently trading at $3.34, which is considered slightly low relative to its 30-day fair value range of $3.22 to $3.82.
Technical Outlook: Technically, RCKT is in a uptrend. Immediate support is located at $3.03, while resistance sits at $3.71.
Market Sentiment: RCKT scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.84 (+164.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RCKT is in a uptrend. Immediate support is located at $3.03, while resistance sits at $3.71.
Market Sentiment: RCKT scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.84 (+164.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.22 -
$3.82
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 164.7% below Wall St target ($8.84)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.22 -
$3.82
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.03
Resistance Level
$3.71
Current Trend
Uptrend
Technical data as of
Aug 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.63
Wall Street Target
$8.84
(+164.7%)
Share & Embed Analysis
Last updated: August 14, 2026 1:14 AM ET
Data refreshes hourly during market hours. Next update: 2:14 AM
Data refreshes hourly during market hours. Next update: 2:14 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCKT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
John Militello
SELL
1157 shares
2026-02-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 63 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 52 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
